Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
On Demand
Favorite
Facebook
Tweet
Print
Helio Sader
Disclosure(s): United States Food and Drug Administration: FDA Contract Number: 75F40123C00140
Poster(s):
(P-1229) Characterization of Ampicillin (AMP) and Vancomycin (VAN) Pharmacokinetics-Pharmacodynamics (PK-PD) in a Neutropenic Murine Invasive Enterococcal Infection Model
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
(P-1313) A 10-year Trend on Antimicrobial Resistance of Pseudomonas aeruginosa from United States Medical Centers: Results from the INFORM Surveillance Program (2015-2024)
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
(P-1314) Activity of aztreonam-avibactam against Enterobacterales isolated from patients with intra-abdominal infection from Europe, Asia, and Latin America (2020-2024).
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
(P-1315) Activity of Aztreonam-avibactam and Ceftazidime-Avibactam against Enterobacterales and Pseudomonas aeruginosa Causing Infections in Immunosuppressed Patients from United States Medical Centers (2019-2024)
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
(P-1316) Activity of Aztreonam-Avibactam and Comparators against Difficult-To-Treat Resistant (DTR) Enterobacterales from United States Medical Centers (2020-2024).
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
(P-1317) Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents Tested against Enterobacterales from European Hospitals Analysed by Infection Type (2022-2024)
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
(P-1318) Antimicrobial Activity of Aztreonam-Avibactam and Comparator Agents against Stenotrophomonas maltophilia Isolates from Patients Hospitalized with Pneumonia in Europe, Latina America, and Asia (2020-2024).
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
(P-1319) Antimicrobial Activity of Aztreonam-Avibactam and Molecular Characterization of Enterobacterales Resistant to Ceftazidime-Avibactam and/or Meropenem-Vaborbactam from United States Medical Centers (2016-2024)
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
(P-1320) Antimicrobial susceptibility of S. maltophilia and B. cepacia species complex isolated from patients with pneumonia in United States hospitals (2022-2024).
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
(P-1332) Activity of aztreonam-avibactam tested against genetically characterized non-carbapenemase producing carbapenem-resistant Enterobacterales
Tuesday, October 21, 2025
12:15 PM - 1:30 PM
US ET
